Back to search
FDAFDA · Food and drugs·Recall number D-0609-2020

Fluphenazine Decanoate Injection USP 125mg/5mL, (5 mL Multiple Dose Vial), Rx only, For IM or SC Use, Mfd in India for: AuroMedics Pharma, LLC, E. Windsor, NJ

Published December 11, 2019 · Recall initiated: November 12, 2019

Summary

FDA records drug Class II recall D-0609-2020, published December 11, 2019 and initiated November 12, 2019. Recalling firm: AuroMedics Pharma LLC; Status: Terminated; Reported quantity: 59,500 vials; Lot: Lot CFD190004, exp. date August 2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Discoloration; Hazy solution found in one vial instead of a clear solution.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
AuroMedics Pharma LLC
Distributor
Product was distributed to major wholesalers/distributors who may have further distribute the product throughout the United States.
Lot
Lot CFD190004, exp. date August 2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fluphenazine Decanoate Injection USP 125mg/5mL, (5 mL Multiple Dose Vial), Rx only, For IM or SC Use, Mfd in India for: AuroMedics Pharma, LLC, E. Windsor, NJ recalled?

Yes. FDA published recall D-0609-2020 on December 11, 2019. Reported hazard: Discoloration; Hazy solution found in one vial instead of a clear solution.

What should I do if I have this product?

Voluntary: Firm initiated · Letter